Stock Events

Stock Events

Priveterra Acquisition Corp Unit 

$10.96
41
+$0+0% Thursday 22:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
81.19
Dividend Yield
-
Dividend
-

Earnings

6MayExpected
Q2 2021
Q1 2022
Q2 2022
Q3 2022
Q3 2023
Q4 2023
Q1 2024
0.05
0.09
0.13
0.16
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Profitable
2020
2021
2022
0Revenue
9.98MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PMGMU. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Evolus
EOLS
Mkt Cap330.5M
Evolus directly competes with AEON Biopharma in the aesthetic and therapeutic botulinum toxin products sector.
Abbvie
ABBV
Mkt Cap368.57B
AbbVie, through its acquisition of Allergan, competes in the botulinum toxin market, particularly in therapeutic areas.
Merck
MRK
Mkt Cap294.39B
Merck & Co., Inc. competes in the broader pharmaceuticals market, including areas that overlap with AEON Biopharma's focus.
Pfizer
PFE
Mkt Cap156.77B
Pfizer competes in the pharmaceuticals sector, including development of products that could compete with AEON Biopharma's offerings.
Bristol-Myers Squibb
BMY
Mkt Cap122.85B
Bristol Myers Squibb competes in the pharmaceutical industry, potentially overlapping with AEON Biopharma's therapeutic areas.
GSK
GSK
Mkt Cap117.55B
GlaxoSmithKline competes in the pharmaceutical and healthcare sector, including areas relevant to AEON Biopharma's market.
Novartis
NVS
Mkt Cap293.34B
Novartis competes in the global healthcare market, including in therapeutic areas that may overlap with AEON Biopharma's focus.
Johnson & Johnson
JNJ
Mkt Cap564.35B
Johnson & Johnson competes across the healthcare spectrum, including pharmaceuticals that could compete with AEON Biopharma's products.

About

Priveterra Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the medical technology sector. The company was incorporated in 2020 and is based in Fort Lauderdale, Florida.
Show more...
CEO
Country
United States
ISIN
US74275N2018

Listings

BOATS
BOATS
AEON.BOATS
XASE
US
AEON

0 Comments

Share your thoughts

FAQ

What is Priveterra Acquisition Corp Unit stock price today?▼
The current price of PMGMU is $10.96 USD — it has increased by +0% in the past 24 hours. Watch Priveterra Acquisition Corp Unit stock price performance more closely on the chart.
What is Priveterra Acquisition Corp Unit stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Priveterra Acquisition Corp Unit stocks are traded under the ticker PMGMU.
What is Priveterra Acquisition Corp Unit revenue for the last year?▼
Priveterra Acquisition Corp Unit revenue for the last year amounts to 0 USD.
What is Priveterra Acquisition Corp Unit net income for the last year?▼
PMGMU net income for the last year is 9.98M USD.
In which sector is Priveterra Acquisition Corp Unit located?▼
Priveterra Acquisition Corp Unit operates in the Other sector.
When did Priveterra Acquisition Corp Unit complete a stock split?▼
Priveterra Acquisition Corp Unit has not had any recent stock splits.